Cubist Systematic Strategies Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Synopsys
SNPS
|
+$56.4M |
| 2 |
SLB Ltd
SLB
|
+$44.8M |
| 3 |
Micron Technology
MU
|
+$42.1M |
| 4 |
Starbucks
SBUX
|
+$39.4M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$39.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
McDonald's
MCD
|
+$79.9M |
| 2 |
Elevance Health
ELV
|
+$74.4M |
| 3 |
Adobe
ADBE
|
+$63.6M |
| 4 |
Nike
NKE
|
+$56.7M |
| 5 |
Dollar General
DG
|
+$51.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 47.45% |
| 2 | Technology | 11.72% |
| 3 | Consumer Discretionary | 8.94% |
| 4 | Healthcare | 6.55% |
| 5 | Industrials | 6.05% |
Similar funds
Cubist Systematic Strategies's Q4 2023 Portfolio in Review
As of Q4 2023, Cubist Systematic Strategies held 4,279 positions worth $15.4B, up 14% from $13.5B the previous quarter. Its ten largest holdings account for 4.6% of the portfolio.
Cubist Systematic Strategies withdrew a net $802M in Q4 2023, closing 766 positions and reducing 1,089 holdings. Its most notable exit was McDonald's, an estimated $79.9M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 47% of assets, up from 40% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, Cubist Systematic Strategies opened a new position in Synopsys worth $56.8M.
- Cubist Systematic Strategies's largest Q4 2023 buy was Synopsys: 110,316 shares worth $56.8M.
- Cubist Systematic Strategies added most to Starbucks in Q4 2023, an estimated $39.4M increase.
- Cubist Systematic Strategies's biggest Q4 2023 reduction was Elevance Health, cutting an estimated $74.4M.
- Cubist Systematic Strategies fully exited McDonald's in Q4 2023, selling an estimated $79.9M.
- Cubist Systematic Strategies's ten largest holdings make up 4.6% of its $15.4B portfolio in Q4 2023.
- Cubist Systematic Strategies opened 1,019 new positions and closed 766 in Q4 2023.
- Cubist Systematic Strategies's portfolio value rose 14% quarter-over-quarter to $15.4B.
Based on Cubist Systematic Strategies's 13F filing for Q4 2023, filed 14 Feb 2024.